Treatment(s) already received-Lumpectomy Posts on Medivizor
Navigation Menu

Treatment(s) already received-Lumpectomy Posts on Medivizor

Comparing the long-term effectiveness of accelerated partial breast irradiation using multicatheter brachytherapy with whole-breast irradiation in patients with early breast cancer

Comparing the long-term effectiveness of accelerated partial breast irradiation using multicatheter brachytherapy with whole-breast irradiation in patients with early breast cancer

Posted by on May 28, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the long-term effectiveness of accelerated partial breast irradiation (ABPI) using multicatheter brachytherapy (BT) with whole-breast irradiation (WBI) in patients with early breast cancer (BC). The study found that ABPI using multicatheter BT was similarly effective with fewer serious side effects compared to...

Read More

Evaluating the role of radiotherapy in HER2+ early-stage breast cancer after breast-conserving surgery

Evaluating the role of radiotherapy in HER2+ early-stage breast cancer after breast-conserving surgery

Posted by on Mar 5, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of radiotherapy (RT) in patients with HER2+ early-stage breast cancer (BC) after breast-conserving surgery (BCS). The study found that RT improved the survival rates of these patients, especially for those high-risk. Some background BC is categorized based on the absence or...

Read More

Evaluating the effectiveness of three exercise programs and intensive follow-up in improving quality of life, pain, and lymphedema among breast cancer survivors

Evaluating the effectiveness of three exercise programs and intensive follow-up in improving quality of life, pain, and lymphedema among breast cancer survivors

Posted by on Feb 5, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of three exercise programs in improving quality of life (QOL), pain, and lymphedema among breast cancer (BC) survivors. The study found that joint mobility exercise (JME) combined with progressive resistance exercise (PRE) showed promising results in improving QOL and lymphedema after BC...

Read More

Effects of adherence to homone therapy after surgery and radiation on the outcomes of older patients with early-stage breast cancer

Effects of adherence to homone therapy after surgery and radiation on the outcomes of older patients with early-stage breast cancer

Posted by on Jun 13, 2021 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the effects of adherence to hormonal therapy (HT) and radiation on the outcomes of older patients with early-stage breast cancer (BC).   This study concluded that the lack of adherence to HT and omitting radiation can lead to poorer outcomes for these...

Read More

Does radiotherapy with electrons boost during surgery reduce the risk of breast cancer recurrence?

Does radiotherapy with electrons boost during surgery reduce the risk of breast cancer recurrence?

Posted by on May 16, 2021 in Breast cancer | 0 comments

In a nutshell The authors investigated whether intra-operative electron radiotherapy (IOERT) boost reduces breast cancer recurrence compared to standard radiotherapy. They found that IOERT slightly reduced cancer recurrence compared to standard external beam radiotherapy (EBRT). Some background Breast cancer is the most commonly diagnosed...

Read More

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Posted by on Feb 6, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the role of circulating tumor cells (CTCs) in deciding adjuvant therapy (AT; treatment after surgery) in patients with breast cancer (BC). This study showed that personalized AT based on CTCs improved patient survival. Some background BC that has not spread to other areas of the body is called non-metastatic...

Read More

Does the histological grade of early stage breast cancer effect outcomes of older women treated with breast conserving surgery?

Does the histological grade of early stage breast cancer effect outcomes of older women treated with breast conserving surgery?

Posted by on Jan 31, 2021 in Breast cancer | 0 comments

In a nutshell This article was carried out to look at how histological grade (HG) impacts the outcomes of older women with early-stage (ES) breast cancer (BC) treated with breast-conserving therapy (BCS) with or without radiotherapy (RT). The authors found that the treatment of ESBC without RT resulted in a lower cancer-specific survival...

Read More

Long term outcomes of accelerated partial breast irradiation with TomoTherapy in invasive breast cancer treated with breast-conserving surgery

Long term outcomes of accelerated partial breast irradiation with TomoTherapy in invasive breast cancer treated with breast-conserving surgery

Posted by on Dec 14, 2020 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the outcomes of accelerated partial breast irradiation (ABPI) with TomoTherapy (TT) after breast conservative surgery (BCS) in patients with invasive breast cancer.  This study concluded that this treatment is safe and effective with good long-term outcomes in these patients.   Some...

Read More

Searching for patients with early breast cancer to trial a partial-radiation treatment

Posted by on Oct 24, 2019 in Breast cancer | 0 comments

In a nutshell This trial aims to find out what dose of radiation therapy is effective in the shortest time period for women with newly diagnosed breast cancer, or ductal carcinoma in-situ (DCIS). The main outcome that will be measured is if patients experience any side effects. The study is taking place in New Jersey and New York, the United States. The...

Read More

Local disease recurrence in patients with HER2-positive breast cancer: an evaluation of treatment effectiveness

Posted by on Apr 30, 2019 in Breast cancer | 0 comments

In a nutshell This study investigated if trastuzumab (Herceptin)/paclitaxel (Taxol) reduces the risk of local-regional recurrence (LRR) in patients with HER2-positive breast cancer (BC).  They found that this treatment reduced LRR risk in HER2-positive patients.  Some background Breast cancer (BC) is one of the most common cancers....

Read More

Denosumab treatment in HR+ breast cancer

Denosumab treatment in HR+ breast cancer

Posted by on Apr 30, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if adding the medication denosumab (Prolia, Xgeva) to cancer treatment for women with breast cancer reduces the risk of bone fractures. The study found that the patients treated with denosumab survived better, but there was no significant difference in the number of bone fractures. Some background Breast...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor